List of Omidria drug patents

Omidria is owned by Rayner Surgical.

Omidria contains Ketorolac Tromethamine; Phenylephrine Hydrochloride.

Omidria has a total of 13 drug patents out of which 0 drug patents have expired.

Omidria was authorised for market use on 30 May, 2014.

Omidria is available in solution;irrigation dosage forms.

Omidria can be used as maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

The generics of Omidria are possible to be released after 23 April, 2034.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9399040 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(5 months from now)

US8173707 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(5 months from now)

US9278101 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(5 months from now)

US8586633 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(5 months from now)

US9399040

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(11 months from now)

US8173707

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(11 months from now)

US8586633

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(11 months from now)

US9278101

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(11 months from now)

US9486406 RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Oct, 2033

(10 years from now)

US9066856 RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Oct, 2033

(10 years from now)

US9855246 RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Oct, 2033

(10 years from now)

US9486406

(Pediatric)

RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Apr, 2034

(11 years from now)

US9066856

(Pediatric)

RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Apr, 2034

(11 years from now)

Drugs and Companies using KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 May, 2014

Treatment: Maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain

Dosage: SOLUTION;IRRIGATION

How can I launch a generic of OMIDRIA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic